HK1045506B - 氧硫庚英並[6，5-b]二氫吡啶和相關組合物及其製備方法 - Google Patents

氧硫庚英並[6，5-b]二氫吡啶和相關組合物及其製備方法

Info

Publication number
HK1045506B
HK1045506B HK02106888.0A HK02106888A HK1045506B HK 1045506 B HK1045506 B HK 1045506B HK 02106888 A HK02106888 A HK 02106888A HK 1045506 B HK1045506 B HK 1045506B
Authority
HK
Hong Kong
Prior art keywords
oxathiepino
dihydropyridines
methods
related compositions
compositions
Prior art date
Application number
HK02106888.0A
Other languages
English (en)
Other versions
HK1045506A1 (en
Inventor
H Dodd John
R Henry James
C Rupert Kenneth
L Bullington James
A Hall Daniel
Original Assignee
Ortho-Mcneil Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho-Mcneil Pharmaceutical Inc filed Critical Ortho-Mcneil Pharmaceutical Inc
Publication of HK1045506A1 publication Critical patent/HK1045506A1/xx
Publication of HK1045506B publication Critical patent/HK1045506B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D497/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D497/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D497/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/06—Anti-spasmodics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
HK02106888.0A 1999-07-12 2002-09-20 氧硫庚英並[6，5-b]二氫吡啶和相關組合物及其製備方法 HK1045506B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14335499P 1999-07-12 1999-07-12
PCT/US2000/017310 WO2001004124A1 (en) 1999-07-12 2000-06-23 OXATHIEPINO[6,5-b]DIHYDROPYRIDINES, AND RELATED COMPOSITIONS AND METHODS

Publications (2)

Publication Number Publication Date
HK1045506A1 HK1045506A1 (en) 2002-11-29
HK1045506B true HK1045506B (zh) 2006-02-03

Family

ID=22503704

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02106888.0A HK1045506B (zh) 1999-07-12 2002-09-20 氧硫庚英並[6，5-b]二氫吡啶和相關組合物及其製備方法

Country Status (22)

Country Link
US (1) US6476022B1 (zh)
EP (1) EP1200446B1 (zh)
JP (1) JP2003504373A (zh)
KR (1) KR20020012308A (zh)
CN (1) CN1188416C (zh)
AR (1) AR030396A1 (zh)
AT (1) ATE302206T1 (zh)
AU (1) AU779498B2 (zh)
BR (1) BR0012386A (zh)
CA (1) CA2379199A1 (zh)
CZ (1) CZ2002126A3 (zh)
DE (1) DE60022056T2 (zh)
DK (1) DK1200446T3 (zh)
ES (1) ES2246248T3 (zh)
HK (1) HK1045506B (zh)
HU (1) HUP0202265A3 (zh)
IL (2) IL147540A0 (zh)
MX (1) MXPA02000436A (zh)
PL (1) PL352760A1 (zh)
RU (1) RU2257388C2 (zh)
TW (1) TWI256394B (zh)
WO (1) WO2001004124A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200503733A (en) * 2003-03-28 2005-02-01 Nissan Chemical Ind Ltd T-shaped channel blockers

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA429975A (en) 1945-09-11 F. D'alelio Gaetano Triazine derivative
US4483985A (en) 1978-10-31 1984-11-20 Bayer Aktiengesellschaft Production of 1,4-dihydropyridinecarboxylic acids
US4285955A (en) 1978-10-31 1981-08-25 Bayer Aktiengesellschaft 1,4-Dihydropyridinecarboxylic acids
NZ201395A (en) 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
JPS58201764A (ja) 1982-05-17 1983-11-24 Maruko Seiyaku Kk ジヒドロピリジン誘導体
JPS6139760A (ja) 1984-07-31 1986-02-25 Toshiba Electric Equip Corp 集合住宅用インタ−ホン装置
JPS62253161A (ja) 1986-01-29 1987-11-04 Fuji Photo Film Co Ltd カラ−画像形成法
US4845225A (en) 1986-04-09 1989-07-04 Ortho Pharmaceutical Corporation Substituted thiacycloalkeno [3,2-b] pyridines
US4777167A (en) 1986-04-09 1988-10-11 Ortho Pharmaceutical Corporation Pharmaceutically useful substituted thiacycloalkeno [3,2-b]pyridines, compositions and method of use
US4879384A (en) 1988-06-15 1989-11-07 Ortho Pharmaceutical Corporation Preparation of thiocycloalkno [3,2-b] pyridines
US5075440A (en) 1990-05-03 1991-12-24 Ortho Pharmaceutical Corporation Novel pyrido[2,3-f](1,4)thiazepines and pyrido[3,2-b](1,5)benzothiazepines
DE19532320A1 (de) 1995-09-01 1997-03-06 Bayer Ag Verfahren zur Herstellung von optisch aktiven ortho-substituierten 4-Aryl-Dihydropyridinen
PT1192163E (pt) * 1999-06-14 2004-01-30 Ortho Mcneil Pharm Inc Ditiepino¬6,5-b|piridinas e composicoes e metodos relacionados

Also Published As

Publication number Publication date
DE60022056T2 (de) 2006-06-08
HUP0202265A2 (en) 2002-10-28
AR030396A1 (es) 2003-08-20
CN1372563A (zh) 2002-10-02
JP2003504373A (ja) 2003-02-04
DK1200446T3 (da) 2005-10-24
CZ2002126A3 (cs) 2003-04-16
WO2001004124A1 (en) 2001-01-18
EP1200446B1 (en) 2005-08-17
HK1045506A1 (en) 2002-11-29
HUP0202265A3 (en) 2004-12-28
RU2257388C2 (ru) 2005-07-27
IL147540A (en) 2006-12-10
IL147540A0 (en) 2002-08-14
US6476022B1 (en) 2002-11-05
ES2246248T3 (es) 2006-02-16
PL352760A1 (en) 2003-09-08
MXPA02000436A (es) 2002-10-11
DE60022056D1 (de) 2005-09-22
CA2379199A1 (en) 2001-01-18
KR20020012308A (ko) 2002-02-15
TWI256394B (en) 2006-06-11
BR0012386A (pt) 2002-05-28
ATE302206T1 (de) 2005-09-15
CN1188416C (zh) 2005-02-09
EP1200446A1 (en) 2002-05-02
AU6605000A (en) 2001-01-30
AU779498B2 (en) 2005-01-27

Similar Documents

Publication Publication Date Title
AUPQ419099A0 (en) Novel compositions and methods
PL354809A1 (en) Piperidine quinolyl propyl derivatives, preparation method and compositions containing same
EP1176948A4 (en) COMPOSITIONS AND METHODS
PL350427A1 (en) Phenyl− and pyridinyl derivatives as neurokinin 1 antagonists
HUP0103341A3 (en) Azetidine derivatives, preparation and pharmaceutical compositions thereof
GB9920678D0 (en) Sanitising compositions and methods
AP2001002300A0 (en) Hiv immunogenic compositions and methods
GB9819979D0 (en) Sanitising compositions and methods
EP1056457A4 (en) S-LANSOPRAZOLE COMPOSITIONS AND METHODS OF USE
PL352432A1 (en) Neurothrophic pyrolydines and piperidines, their affinite composition and methods of using them
EP1113815A4 (en) IMMUNOGENIC COMPOSITIONS AND USES THEREOF
HUP0105028A3 (en) Compositions having improved stability and process for their preparation
EP1073333A4 (en) S-RABEPRAZOL COMPOSITIONS AND METHODS
AU3883800A (en) Hob-bp2h compositions, methods and uses thereof
AU1018801A (en) Use of 3,4-substituted piperidines
GB9917593D0 (en) Compound, composition, process and use
GB9922135D0 (en) Compositions and uses
AU4732001A (en) Thiepino (3,2-b) dihydropyridines and related compositions and methods
HK1045506B (zh) 氧硫庚英並[6，5-b]二氫吡啶和相關組合物及其製備方法
IL147128A0 (en) DITHIEPINO [6,5-b]PYRIDINES, AND RELATED COMPOSITIONS AND METHODS
AU4566399A (en) Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents
AU5606400A (en) Neurotrophic tetrahydroisoquinolines and tetrahydrothienopyridines, and related compositions and methods
EP1073332A4 (en) R-RABEPRAZOL COMPOSITIONS AND METHODS
AU1623801A (en) Opioid metallopeptide compositions and methods
AU5931300A (en) Ringene compositions and methods for use thereof

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20090623